Scrip
Par Pharma launches generic Ultram ER in US
20 November 2009
Nancy Faigen
Please Login to read the full article.
20 November 2009
Nancy Faigen
Par Pharmaceutical has gained final US FDA approval of its extended-release tramadol product in 100mg and 200mg strengths, a generic version of Ortho-McNeil's (
Johnson & Johnson) once-daily Ultram ER. Following the approval on November 13th, Par immediately began shipping the analgesic,...
Please Login to read the full article.
RELATED CONTENT
NEWS
- French industry welcomes moves to boost the biopharmaceutical sector
- US Justice files suit charging J&J paid kickbacks to induce prescriptions
- US panel calls for phased launch of Neuromed/Covidien's long-acting opioid Exalgo
- Watson's generic Toprol XL may gain from two US rivals' withdrawals
COMMENT
Other Informa Comment
FEATURES
- Archimedes – a fast mover in a niche sector
- Face to face: Ex-Novartis manager takes two-step approach to women's health at Lumavita
EVENTS
22 March 2010
London, UK
12 April 2010
Orlando, Florida
13 April 2010
London, UK
JOB OF THE WEEK
Promote your vacancy here
DIRECTORY
Scrip Directory 2009
